Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026

Eli Lilly is further strengthening its position in immunology with its 13th acquisition of the year, paying up to $2.875 billion for Merida Biosciences and its asset in the increasingly popular subfields ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 31 August →